Licheng Shi

1.2k total citations
18 papers, 781 citations indexed

About

Licheng Shi is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Epidemiology. According to data from OpenAlex, Licheng Shi has authored 18 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Licheng Shi's work include Neuropeptides and Animal Physiology (5 papers), Virus-based gene therapy research (3 papers) and Migraine and Headache Studies (3 papers). Licheng Shi is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Virus-based gene therapy research (3 papers) and Migraine and Headache Studies (3 papers). Licheng Shi collaborates with scholars based in United States, China and Sweden. Licheng Shi's co-authors include Donald F. Summers, Martin Schwemmle, W. Ian Lipkin, Narender R. Gavva, Todd W. Vanderah, Vellarkad N. Viswanadhan, Larry V. Pearce, Jose M. Galarza, Peter M. Blumberg and Frank Porreca and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Pain.

In The Last Decade

Licheng Shi

18 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Licheng Shi United States 12 280 242 193 175 170 18 781
Debapriya Ghosh Belgium 22 416 1.5× 574 2.4× 80 0.4× 248 1.4× 229 1.3× 28 1.6k
Ana Paula Luiz Brazil 18 159 0.6× 405 1.7× 63 0.3× 453 2.6× 286 1.7× 43 1.1k
Suresh K. Mendu United States 12 68 0.2× 339 1.4× 87 0.5× 139 0.8× 127 0.7× 13 899
Zili Xie China 17 178 0.6× 402 1.7× 19 0.1× 186 1.1× 97 0.6× 34 854
Tamia K. Lapointe Canada 12 181 0.6× 235 1.0× 59 0.3× 112 0.6× 64 0.4× 16 815
Lusine Demirkhanyan United States 14 327 1.2× 302 1.2× 30 0.2× 69 0.4× 127 0.7× 29 825
Tim T. Lambers Netherlands 18 175 0.6× 595 2.5× 94 0.5× 132 0.8× 55 0.3× 32 1.2k
Agathe Gelot France 11 48 0.2× 600 2.5× 45 0.2× 326 1.9× 150 0.9× 14 1.1k
Justyna B. Startek Belgium 11 346 1.2× 259 1.1× 21 0.1× 119 0.7× 137 0.8× 14 738
Bumsup Kwon United States 15 46 0.2× 255 1.1× 87 0.5× 135 0.8× 55 0.3× 26 642

Countries citing papers authored by Licheng Shi

Since Specialization
Citations

This map shows the geographic impact of Licheng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Licheng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Licheng Shi more than expected).

Fields of papers citing papers by Licheng Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Licheng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Licheng Shi. The network helps show where Licheng Shi may publish in the future.

Co-authorship network of co-authors of Licheng Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Licheng Shi. A scholar is included among the top collaborators of Licheng Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Licheng Shi. Licheng Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gao, Jia, et al.. (2023). Association of obstructive sleep apnea with cardiometabolic diseases and cardiovascular mortality. The Clinical Respiratory Journal. 17(8). 764–770. 11 indexed citations
2.
Sun, Min, Hongmei Guo, Lu Gan, et al.. (2022). Verbascoside protects from LPS-induced septic cardiomyopathy via alleviating cardiac inflammation, oxidative stress and regulating mitochondrial dynamics. Ecotoxicology and Environmental Safety. 233. 113327–113327. 37 indexed citations
3.
Shi, Licheng, et al.. (2022). Triglyceride Glucose Index Was a Predictor of 6-Month Readmission Caused by Pulmonary Infection of Heart Failure Patients. International Journal of Endocrinology. 2022. 1–6. 6 indexed citations
4.
Gao, Jia, et al.. (2021). Difference of immune cell infiltration between stable and unstable carotid artery atherosclerosis. Journal of Cellular and Molecular Medicine. 25(23). 10973–10979. 22 indexed citations
5.
Hu, Essa, Fang‐Tsao Hong, Derek E. Piper, et al.. (2021). Discovery of Selective Pituitary Adenylate Cyclase 1 Receptor (PAC1R) Antagonist Peptides Potent in a Maxadilan/PACAP38-Induced Increase in Blood Flow Pharmacodynamic Model. Journal of Medicinal Chemistry. 64(6). 3427–3438. 6 indexed citations
6.
Hoffmann, Jan, Silke Miller, Margarida Martins-Oliveira, et al.. (2020). PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?. Pain. 161(7). 1670–1681. 51 indexed citations
8.
Moyer, Bryan D., Justin K. Murray, Joseph Ligutti, et al.. (2018). Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V. PLoS ONE. 13(5). e0196791–e0196791. 35 indexed citations
9.
Wei, Feng, Licheng Shi, Qiang Wang, & Yingxian Zhao. (2018). Fast and accurate separation of the paclitaxel from yew extracum by a pseudo simulated moving bed with solvent gradient. Journal of Chromatography A. 1564. 120–127. 11 indexed citations
10.
Miller, Silke, Hantao Liu, Karin Warfvinge, et al.. (2016). Immunohistochemical localization of the calcitonin gene-related peptide binding site in the primate trigeminovascular system using functional antagonist antibodies. Neuroscience. 328. 165–183. 60 indexed citations
11.
Miranda, Les P., Licheng Shi, Jerry Ryan Holder, et al.. (2013). Peptide antagonists of the calcitonin gene‐related peptide (CGRP) receptor with improved pharmacokinetics and pharmacodynamics. Biopolymers. 100(4). 422–430. 10 indexed citations
12.
Miranda, Les P., Jerry Ryan Holder, Licheng Shi, et al.. (2008). Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor. Journal of Medicinal Chemistry. 51(24). 7889–7897. 28 indexed citations
13.
Gavva, Narender R., Lana Klionsky, Yusheng Qu, et al.. (2004). Molecular Determinants of Vanilloid Sensitivity in TRPV1. Journal of Biological Chemistry. 279(19). 20283–20295. 292 indexed citations
14.
Schwemmle, Martin, et al.. (1998). Interactions of the Borna Disease Virus P, N, and X Proteins and Their Functional Implications. Journal of Biological Chemistry. 273(15). 9007–9012. 68 indexed citations
15.
Schwemmle, Martin, Bishnu P. De, Licheng Shi, Amiya K. Banerjee, & W. Ian Lipkin. (1997). Borna Disease Virus P-protein Is Phosphorylated by Protein Kinase Cε and Casein Kinase II. Journal of Biological Chemistry. 272(35). 21818–21823. 55 indexed citations
16.
Peng, Qinghai, Jose M. Galarza, Licheng Shi, & Donald F. Summers. (1996). Influenza A virus RNA-dependent RNA polymerase cleaves influenza mRNA in vitro. Virus Research. 42(1-2). 149–158. 3 indexed citations
17.
Shi, Licheng, et al.. (1996). Recombinant-baculovirus-expressed PB2 subunit of the influenza A virus RNA polymerase binds cap groups as an isolated subunit. Virus Research. 42(1-2). 1–9. 21 indexed citations
18.
Shi, Licheng, Donald F. Summers, Qinghai Peng, & Jose M. Galarza. (1995). Influenza A Virus RNA Polymerase Subunit PB2 Is the Endonuclease Which Cleaves Host Cell mRNA and Functions Only as the Trimeric Enzyme. Virology. 208(1). 38–47. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026